Valetudo Transfers 4.3M Shares to Ewon Comfortech, Strengthening Voting Power in LIMINATUS PHARMA
Valetudo Therapeutics’ $0.14 per‑share transfer to Ewon Comfortech consolidates voting power, reshaping LIMINATUS PHARMA’s governance and could spark renewed product development and strategic moves without new capital.
3 minutes to read